Fresenius offers international diversification, stable healthcare exposure, and upside from a strategic pivot. Find out why ...

Fresenius Medical Care AG & Co. FMS is well-poised for growth on the back of strategic acquisitions and partnerships and a ...

Fresenius Medical Care (FME) has commenced the US commercialisation of its high-volume haemodiafiltration (HVHDF) kidney ...

Citi raised the firm’s price target on Fresenius SE (FSNUY) to EUR 52 from EUR 43 and keeps a Buy rating on the shares. Published first on TheFly ...

Fresenius SE FRE0.21%increase; green up pointing triangle said it raised around 1.1 billion euros ($1.15 billion) after selling part of its Fresenius Medical Care FME 0.20%increase; green up ...

Fresenius (FMS) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the ...

In this article, I'm going to be updating on and taking a closer look at the future potential of Fresenius Medical Care (OTCPK:FMCQF) (NYSE:FMS). The company has seen a bit of recovery in the ...

Fresenius SE raised close to €1.1 billion ($1.2 billion) in a sale of shares in Fresenius Medical Care AG as well as exchangeable bonds linked to the dialysis firm, as it looks to cut debt and ...

Fresenius SE issued a dividend for 2024 and forecast growth in earnings and sales for this year on higher fourth-quarter profit and revenue, lifting its shares. In European morning trading ...

Fresenius Kabi Canada, part of Fresenius group, announced the recent launch of Iodixanol Injection 270 and 320 for both the ...

Fresenius Medical Care AG & Co. FMS is well-poised for growth on the back of strategic acquisitions and partnerships and a solid global foothold. However, a tough regulatory environment remains a ...